Clinical Trials Browser

Astrocytoma, Glioblastoma, Glioma

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma

Astrocytoma, Glioma, Oligodendroglioma

Glioblastoma

Brain Neoplasms, Glioma, Neoplasms, Spinal Cord Neoplasms

Esophageal Neoplasms, Neoplasms

Paraganglioma, Pheochromocytoma

Neuroblastoma

Advanced Melanoma

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Glioblastoma

Somatostatinoma, Carcinoma, Neuroendocrine

Leiomyosarcoma, Sarcoma

Small Cell Lung Carcinoma

Brain Neoplasms, Glioblastoma

Glioblastoma

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Neoplasm Metastasis, Sarcoma, Ewing

Lung Neoplasms, Small Cell Lung Carcinoma

Gastrointestinal Stromal Tumors

Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Glioblastoma

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Neuroblastoma

Colorectal Adenocarcinoma

Adenoma, Islet Cell

Glioblastoma

Colorectal Neoplasms, Microsatellite Instability

Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Ependymoma, Medulloblastoma, Recurrence

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Neuroblastoma

Neuroblastoma

Glioblastoma

Ependymoma, Medulloblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Primary Glioblastoma

Glioblastoma

Astrocytoma, Glioblastoma, Oligodendroglioma

Clinical Trials

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Pan Tumor Rollover Study

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

DERIVe

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

ELEVATE

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

BEACON

A Phase II Trial of LM103 in Advanced Melanoma

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

ARISTOCRAT

G-CSF After Chemo-radiation in Patients With Glioblastoma

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

PNOC031

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

GIST

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

CAMPFIRE

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Surgical Pembro +/- Olaparib w TMZ for rGBM

ARETHUSA

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

MEMMAT

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

2-THE-TOP

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

MATVAC-1

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas